[HTML][HTML] Hereditary ataxias: overview

S Jayadev, TD Bird - Genetics in Medicine, 2013 - Elsevier
The hereditary ataxias are a highly heterogeneous group of disorders phenotypically
characterized by gait ataxia, incoordination of eye movements, speech, and hand …

Clinical features of Friedreich's ataxia: classical and atypical phenotypes

MH Parkinson, S Boesch, W Nachbauer… - Journal of …, 2013 - Wiley Online Library
One hundred and fifty years since Nikolaus Friedreich's first description of the degenerative
ataxic syndrome which bears his name, his description remains at the core of the classical …

Hereditary spastic paraplegia: clinicogenetic lessons from 608 patients

R Schüle, S Wiethoff, P Martus, KN Karle… - Annals of …, 2016 - Wiley Online Library
Objective Hereditary spastic paraplegias (HSPs) are genetically driven disorders with the
hallmark of progressive spastic gait disturbance. To investigate the phenotypic spectrum …

Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: a cross-sectional analysis of baseline …

K Reetz, I Dogan, AS Costa, M Dafotakis… - The Lancet …, 2015 - thelancet.com
Background Friedreich's ataxia is a rare autosomal recessive neurodegenerative disorder.
Here we report cross-sectional baseline data to establish the biological and clinical …

Natural history of Friedreich ataxia: heterogeneity of neurologic progression and consequences for clinical trial design

C Rummey, LA Corben, M Delatycki, G Wilmot… - Neurology, 2022 - AAN Enterprises
Background and Objectives The understanding of the natural history of Friedreich ataxia
(FRDA) has improved considerably recently, but patterns of neurologic deterioration are not …

Assessment of ataxia rating scales and cerebellar functional tests: critique and recommendations

S Perez‐Lloret, B Van de Warrenburg… - Movement …, 2021 - Wiley Online Library
Background We assessed the clinimetric properties of ataxia rating scales and functional
tests, and made recommendations regarding their use. Methods A systematic literature …

Progression characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS): a 2 year cohort study

K Reetz, I Dogan, RD Hilgers, P Giunti… - The Lancet …, 2016 - thelancet.com
Summary Background The European Friedreich's Ataxia Consortium for Translational
Studies (EFACTS) is a prospective international registry investigating the natural history of …

Deferiprone in F riedreich ataxia: a 6‐Month randomized controlled trial

M Pandolfo, J Arpa, MB Delatycki… - Annals of …, 2014 - Wiley Online Library
Objective We conducted a 6‐month, randomized, double‐blind, placebo‐controlled study to
assess safety, tolerability, and efficacy of deferiprone in Friedreich ataxia (FRDA). Methods …

[HTML][HTML] Friedreich ataxia

SI Bidichandani, MB Delatycki, M Napierala… - GeneReviews® …, 2024 - ncbi.nlm.nih.gov
Typical Friedreich ataxia (FRDA) is characterized by progressive ataxia with onset from early
childhood to early adulthood with mean age at onset from 10 to 15 years (range: age two …

An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels

EM Yiu, G Tai, RE Peverill, KJ Lee, KD Croft, TA Mori… - Journal of …, 2015 - Springer
Friedreich ataxia (FRDA) is due to a triplet repeat expansion in FXN, resulting in deficiency
of the mitochondrial protein frataxin. Resveratrol is a naturally occurring polyphenol …